Skip to content

Drug interactions

Givosiran + Paroxetine

Severity: Moderate

Givosiran and Paroxetine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Givosiran can reduce CYP2D6 activity, which may raise exposure to sensitive CYP2D6 substrates. Paroxetine is metabolized by CYP2D6 and itself inhibits it, so levels may rise and adverse effects may increase.

What this interaction means in plain words

Givosiran and Paroxetine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Givosiran belongs to Miscellaneous; Paroxetine belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Givosiran-associated reduction in CYP2D6 activity decreases paroxetine clearance.

What to do

Monitor for paroxetine adverse effects such as nausea, sedation, and serotonergic symptoms, and reduce the dose if they occur. Follow labeling guidance on CYP2D6 substrate dose reduction.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Givosiran and Paroxetine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Givosiran with Paroxetine?

MediHelp rates the interaction as moderate. Givosiran and Paroxetine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Givosiran can reduce CYP2D6 activity, which may raise exposure to sensitive CYP2D6 substrates. Paroxetine is metabolized by CYP2D6 and itself inhibits it, so levels may rise and adverse effects may increase.

How serious is the interaction between Givosiran and Paroxetine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for paroxetine adverse effects such as nausea, sedation, and serotonergic symptoms, and reduce the dose if they occur. Follow labeling guidance on CYP2D6 substrate dose reduction.

What other medicines interact with Paroxetine?

MediHelp also lists interactions of Paroxetine with, for example, Isocarboxazid, Methylene blue, Phenelzine. The full list is on the Paroxetine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in